3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
80
Stomach Neoplasms
66
Rectal Neoplasms
39
Pancreatic Neoplasms
31
Colonic Neoplasms
27
Esophageal Neoplasms
24
Lymphoma, Large B-Cell, Diffuse
20
Neoplasms
19
Adenocarcinoma
19
Cholangiocarcinoma
16
Neoplasm Metastasis
15
Adenocarcinoma Of Esophagus
14
Biliary Tract Neoplasms
12
Carcinoma, Non-Small-Cell Lung
11
Parkinson Disease 4, Autosomal Dominant Lewy Body
10
Ovarian Neoplasms
10
Gastrointestinal Neoplasms
7
Gallbladder Neoplasms
7
Carcinoma, Hepatocellular
7
Locally Advanced Rectal Cancer
6
Esophageal Squamous Cell Carcinoma
6
Endometrial Neoplasms
6
Recurrence
4
Lymphoma
4
Carcinoma
4
Bile Duct Neoplasms
4
Advanced Solid Tumors
4
Triple Negative Breast Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Peritoneal Neoplasms
3
Interventions
Cisplatin
15
Pemetrexed
12
pembrolizumab
9
Carboplatin
8
Nivolumab
7
Cyclophosphamide
6
Platinum
5
Ipilimumab
5
1,2-diaminocyclohexaneplatinum II citrate
5
fludarabine
3
Radiotherapy, Intensity-Modulated
3
Interleukin-2
3
Gemcitabine
3
tremelimumab
2
durvalumab
2
atezolizumab
2
aldesleukin
2
Radiotherapy
2
Radiation
2
Photochemotherapy
2
Pharmaceutical Preparations
2
Methotrexate
2
Drug Therapy
2
Chemotherapy, Adjuvant
2
Cerebral Decortication
2
nintedanib
1
methoxyamine
1
decitabine and cedazuridine drug combination
1
cemiplimab
1
cediranib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mesothelioma, Malignant
×
Oxaliplatin
×
1 year
×
Clear all
No trials found.